Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Gross Profit: 2009-2024

Historic Gross Profit for Cross Country Healthcare (CCRN) over the last 16 years, with FY2024 value amounting to $274.3 million.

  • Cross Country Healthcare's Gross Profit fell 2062.25% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $227.6 million, marking a year-over-year decrease of 2482.85%. This contributed to the annual value of $274.3 million for FY2024, which is 3911.06% down from last year.
  • Cross Country Healthcare's Gross Profit amounted to $274.3 million in FY2024, which was down 3911.06% from $450.4 million recorded in FY2023.
  • Cross Country Healthcare's Gross Profit's 5-year high stood at $624.5 million during FY2022, with a 5-year trough of $202.7 million in FY2020.
  • For the 5-year period, Cross Country Healthcare's Gross Profit averaged around $385.4 million, with its median value being $375.0 million (2021).
  • Per our database at Business Quant, Cross Country Healthcare's Gross Profit surged by 8497.28% in 2021 and then plummeted by 3911.06% in 2024.
  • Cross Country Healthcare's Gross Profit (Annual) stood at $202.7 million in 2020, then soared by 84.97% to $375.0 million in 2021, then soared by 66.52% to $624.5 million in 2022, then dropped by 27.87% to $450.4 million in 2023, then plummeted by 39.11% to $274.3 million in 2024.
  • Its last three reported values are $274.3 million in FY2024, $450.4 million for FY2023, and $624.5 million during FY2022.